A prospective cohort study for prognostic value of serum soluble LR11 in patients with acute leukemia and malignant lymphoma (LR11-study)
Not Applicable
- Conditions
- Patients with newly diagnosed, previously untreated acute leukemia and malignant lymphoma.
- Registration Number
- JPRN-UMIN000004032
- Lead Sponsor
- Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Department of Hematology, Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who could not obtain written consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The association of serum soluble LR11 level at diagnosis and complete response rate.
- Secondary Outcome Measures
Name Time Method The association of serum soluble LR11 level and recurrence rate, overall survival rate, and disease free survival rate. The association of serum soluble LR11 levels and previously known predictive markers.